Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Pharmaceutics
|
April 3, 2021
Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs
Dina V Hingorani, Maria F Camargo, Maryam A Quraishi, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses
Kanika Dhawan, Michael M Allevato, Jacqueline Lesperance, et al.
Cancer Discovery
|
September 13, 2017
Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers
Laetitia Seguin, Maria F Camargo, Hiromi I Wettersten, et al.
Cancer Letters
|
June 19, 2026
Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses
Kanika Dhawan, Michael M Allevato, Jacqueline Lesperance, et al.
Molecular Cancer Therapeutics
|
October 11, 2019
Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability
Dina V Hingorani, Matthew K Doan, Maria F Camargo, et al.
Molecules (Basel, Switzerland)
|
December 17, 2024
Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment
Mahsa Mortaja, Marcus M Cheng, Alina Ali, et al.
Biomaterials
|
April 19, 2020
Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors
Dina V Hingorani, Jessica L Crisp, Matthew K Doan, et al.
Plos One
|
December 22, 2006
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer
Claudia Arce, Carlos Pérez-Plasencia, Aurora González-Fierro, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 24, 2025
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy
Jacqueline Lesperance, Bryan S Yung, Michael M Allevato, et al.
Nature Communications
|
July 5, 2022
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
Dina V Hingorani, Michael M Allevato, Maria F Camargo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Pharmaceutics
|
April 3, 2021
Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs
Dina V Hingorani, Maria F Camargo, Maryam A Quraishi, et al.
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses
Kanika Dhawan, Michael M Allevato, Jacqueline Lesperance, et al.
Cancer Discovery
|
September 13, 2017
Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers
Laetitia Seguin, Maria F Camargo, Hiromi I Wettersten, et al.
Cancer Letters
|
June 19, 2026
Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses
Kanika Dhawan, Michael M Allevato, Jacqueline Lesperance, et al.
Molecular Cancer Therapeutics
|
October 11, 2019
Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability
Dina V Hingorani, Matthew K Doan, Maria F Camargo, et al.
Molecules (Basel, Switzerland)
|
December 17, 2024
Tumor-Targeted Cell-Penetrating Peptides Reveal That Monomethyl Auristatin E Temporally Modulates the Tumor Immune Microenvironment
Mahsa Mortaja, Marcus M Cheng, Alina Ali, et al.
Biomaterials
|
April 19, 2020
Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors
Dina V Hingorani, Jessica L Crisp, Matthew K Doan, et al.
Plos One
|
December 22, 2006
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer
Claudia Arce, Carlos Pérez-Plasencia, Aurora González-Fierro, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
October 24, 2025
Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy
Jacqueline Lesperance, Bryan S Yung, Michael M Allevato, et al.
Nature Communications
|
July 5, 2022
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
Dina V Hingorani, Michael M Allevato, Maria F Camargo, et al.
Page
of 2